Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review).
Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review). Oncol Rep. 2012 May; 27(5):1303-11.